Viewing Study NCT05047458


Ignite Creation Date: 2025-12-25 @ 12:19 AM
Ignite Modification Date: 2026-01-06 @ 8:38 PM
Study NCT ID: NCT05047458
Status: COMPLETED
Last Update Posted: 2021-09-17
First Post: 2021-09-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Single-dose ALXN2050 in Healthy Adults
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module